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Parathyroid hormone dependent T cell proliferation in uremic rats.
Chronic renal failure (CRF) is combined with an impairment of the
immune system. The T cell may be a target for the action of parathyroid
hormone (PTH). Rats with CRF have high blood levels of PTH.
Therefore, the present investigation examined some aspects of the T
cell function in both normal and CRF rats before and after parathyroid-
ectomy and after an isogenic kidney transplantation. The T cell prolif-
erative response to phytohemagglutinin (PHA) stimulation was signifi-
cantly higher in peripheral blood mononuclear cell (PBMC) cultures
obtained from CRF rats than from normal rats. After parathyroidec-
tomy the T cells of normal as well as of uremic rats could still be
significantly stimulated by PHA, but now no significant difference was
seen. When CRF was reversed after an isogenic kidney transplantation
and PTH reversed to levels in the normal range, the T cell proliferative
response to PHA was normalized. Rat PTH 1-84 stimulated in vitro the
PHA-induced proliferation of T cells in a dose dependent manner. This
effect was significant in CRF rat lymphocytes, but not in lymphocytes
obtained from normal rats. Based upon the present results it is
suggested that the secondary hyperparathyroidism in chronic uremia is
responsible for the enhanced proliferative response to PHA of T cells
from CRF rats.
Chronic renal failure (CRF) is associated with various abnor-
malities of the immune system and the underlying mechanisms
are not yet fully clarified [1]. Thus, metabolic disturbances in
CRF, uremic toxins, malnutrition, vitamin deficiency, drug
therapy, cause of the uremia and dialysis treatment may each—
individually or combined—promote the impaired immune sys-
tem in CRF [2].
Severe chronic uremia is accompanied by an impaired pro-
duction of 1 ,25(OH),D3 and of a marked secondary hyper-
parathyroidism. In vitro 1 ,25(OH)2D3 has recently been shown
to have a strong influence on the immune system [31,although
equivalent significant clinical investigations are still lacking.
Parathyroid hormone (PTH) has, as well, been shown to
influence the immune system in vitro [11. Thus the polymorpho-
nuclear leukocytes and the T cells are target cells for PTH. In
acute studies PTH enhanced the random migration while pro-
longed exposure to PTH 1-84 adversely affected the random
migration of polymorphonuclear leukocytes [4]. Acting on T
cells both PTH 1-84 and PTH 1-34 augmented the T cell
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proliferation induced by phytohemagglutinin (PHA) and the
interleukin-2 (IL-2) production by the T cell [5]. Clinical immu-
nological studies in uremic patients have shown different and
often contradictionary results [6—9].
The present investigation was designed to examine some
aspects of T cell function using an experimental model of
chronic uremic rats, which consisted of a period of stable
chronic uremia and of a following period of reversible uremia in
inbred rats [10]. With time, the CRF rats developed a marked
secondary hyperparathyroidism which disappeared after a kid-
ney transplantation. The present study focused on the possibil-
ity that chronic exposure of the T cells to excess levels of PTH
in uremia might affect their function. The examined aspects of
the T cell function were the following: (1.) T cell proliferation in
response to phytohemagglutinin (PHA) mitogen in cultures of
peripheral blood mononuclear cells (PBMC) from CRF and
normal rats; (2.) the T cell proliferative response to PHA and
PTH 1-84 in cultures from CRF and normal rats; (3.) the effect
of parathyroidectomy on the T cell response to PHA in PBMC
from CRF and normal rats; and (4.) The effect of reversal of
uremia by an isogenic kidney transplantation on the T cell
proliferative response to PHA.
Methods
Animals
Inbred adult male DA and Lewis rats weighing 250 to 300 g
were studied. They were fed a rat chow diet containing 0.9%
calcium and 0.7% phosphorus.
CRF
CRF was induced by a one-stage 5/6th nephrectomy. Devel-
opment of uremia was monitored by determination of blood
urea and creatinine levels. Only rats with blood urea of more
than 15 mmol/liter were used. The duration of uremia before the
PBMC investigation was at least 12 weeks. The control rats
were subjected to a unilateral nephrectomy, to be compared to
the one-kidney transplanted rats.
Parathyroidectomy
Parathyroidectomy (PTX) was performed by removing both
parathyroid glands. The effectiveness was confirmed by obtain-
ing a fall of plasma Ca of at least 0.25 mmol/liter and of
undetectable PTH levels. Control rats were subjected to a sham
operation by dissection of the lower part of the thyroid glands.
The investigations on PBMC from uremic, normal, and sham
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Normal 5 0.2 72 2 1.6 0.1 1.27 0.01 1.01 0.04 38 3 <20
CRF 25 2 190 18 1.9 0.1 1.27 0.06 0.95 0.05 > 60 <20
Sham PTX 1.27 0.01 33 4
Data are means SCM.
operated rats were performed on the same rats one month
before PTX and again five days after PTX.
Rat model of reversible uremia employing isogenic kidney
transplantation
A period of stable severe uremia was induced by 5/6th
nephrectomy in inbred Lewis rats. Ten weeks later uremia was
reversed by a successful isogenic rat kidney transplantation
necessitating no medical treatment. The kidney was trans-
planted into the left orthopic side with end-to-end anastomoses
of the blood vessels and of the ureter [101.
PBMC and mitogenic assays
Peripheral venous blood was drawn from the rat periorbital
plexus into tubes containing medium RPMI 1640 (GIBCO,
Grand Island, New York, USA), heparin 30 U/mi and garamicin
10 pg/ml of medium. The blood was diluted by an equal volume
of medium. Thus, 6 ml of diluted blood was layered on top of 3
ml of lymphoprep (density 1.077 g/ml; Nycomed, Oslo, Nor-
way). The samples were centrifuged for 30 minutes at 1500 g.
PBMC were recovered from the lymphoprep surface, washed
three times with 10 ml of RPM! 1640 and resuspended in RPM!
1640 supplemented with 10% isogenic rat serum, 2 mercapto-
ethanol (Sigma Chemical Co., St. Louis, Missouri, USA; 3 mM
solution, 10 4/mI medium), and L-glutamin (GIBCO; 200 mri,
1 ml per 100 ml medium). The cells were cultured at a density of
5 X llYVwell in U-bottom, 96-well cell culture clusters, with a
well diameter of 6.4 mm (Nunc Inter Med, DK). Each well
received 150 1d of cells in medium and 20 sl of mitogen dilution.
Phytohemagglutinin P (Difco Lab, USA) was dissolved in
RPMI 1640 to final dilution in the wells of 40, 10 and 5 fLg/ml,
respectively. Rat PTH 1-84 was obtained from Bachem (Cali-
fornia, USA). The bioavailability of the rat PTH 1-84 was
proved in our laboratory by cAMP generation from rat renal
slices, in response to increasing concentrations of the hormone.
PTH was diluted in RPM!. Cultures added PTH were per-
formed with and without extra added CaCl2 (ion calcium of 1
mmollliter and 0.45 mmollliter, respectively). In cultures with-
out PHA or PTH, medium was added to reach a final volume of
190 p1. After 72 hours the cultures were pulsed for 20 hours by
1 pCi of 3H-thymidine, 20 p1/well. The cells were then har-
vested onto glass microfiber paper using an automated cell
harvester and counted in a liquid scintillation counter. Each
determination was performed in triplicate. The proliferation of
lymphocytes was expressed as 3H-thymidine uptake in counts
per minute (CPM).
Radioimmunoassay (RIA) for PTH
This assay (INS-PTH, Nichols Institute) measured rat PTH
1-34 as well as human PTH 1-34 using a chicken antibody raised
against synthetic human PTH 1-34. The tracer was '251-bovine
PTH 1-84. The standards were synthetic human PTH 1-34. This
radioimmunoassay has previously been documented suitable
for measurement of rat PTH [11]. The samples from Lewis and
DA rats were determined in two different assays.
Experimental design
PBMC from 18 DA CRF rats (duration of uremia 12 to 18
weeks), from 17 normal rats of the same age, and from eight
unilateral nephrectomized rats were stimulated with PHA at
three different concentrations: 5, 10, and 40 jsglml.
One month later six of the CRF rats and nine of the normal
rats were PTXed, and eight normal rats were sham PTXed.
After another five days PBMC from these rats were stimulated
with PHA at concentrations of 5, 10, and 40 g/ml. PBMC from
another eight DA CRF rats (duration of uremia 12 to 16 weeks)
and from eight normal rats of the same age were used for in vitro
stimulation with 40 g/ml PHA together with rat PTH 1-84 in
concentrations of i0—, 2 x 1O, and 4 x l0 M (the
concentrations described in the literature as efficient on human
lymphocytes [5]). These cultures were incubated in media of
two different Ca concentrations: 0.45 m and 1 mM.
PBMC of 21 Lewis rats: seven normal rats, seven CRF rats
(duration of uremia 10 weeks), and seven isogenic kidney
transplanted rats (transplanted after 10 weeks of uremia and
used for PBMC 10 weeks after the transplantation) were stim-
ulated with 40 g/ml PHA.
Statistics
All results are expressed as mean SEM. The Student's t-test
is used to compare the results in the different groups. P < 0.05
is considered significant.
Results
5/6 Nephrectomy in rats resulted in stable uremia as shown in
Table 1. After 12 weeks, the rats developed a significant
increase of plasma creatinine and plasma urea (P < 0.001) and
developed a significant secondary hyperparathyroidism (P <
0.05). On the diet given the CRF was not accompanied by
severe hypocalcemia.
Parathyroidectomy resulted in a significant decrease of PTH
levels (P < 0.05) and of plasma Ca (P < 0.05) in both CRF
and normal rats (Table 1). !sogenic kidney transplantation
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P-phosphate P-calcium ion PTH
pg/mlmmol/liter
Before 6.5 0.4 35 5 1.7 0.8 1.29 0.06 52 5
CRF 22.0 2.Oa 106 l2 1.9 0.6 1.27 0.09 122 21'-'
Transplanted 6.8 0.4 35 2 1.9 0.5 1.32 0.06 49 5
Data are mean SEM.
a P < 0.001 vs. normal and vs. transplanted ratsb p < 0.025 vs. normal and vs. transplanted rats
5 j.tg/mt 10 1g/mI 40j.tg/mI
PHA concentration
Fig. 1. T cell prolferation after stimulation with different concentra-(ions of PHA in cultures from CRFDA rats (U, N = 18), normal control
rats (LI, N = 17) and unilateral nephrectomized rats (el), N = 8). Mean






















Fig. 2. T cell proliferative response to PHA stimulation in cultures
from normal DA rats before (U) and (0) after parathyroidectomy
(PTX). N = 9. Data are mean SEM, * P < 0.05 after PTX versus
before PTX.
in a dose dependent manner. The effect was significant (P <
0.05) for CRF rat lymphocytes, but not for lymphocytes ob-
tained from normal rats. The comitogenic effect of PTH could
only be observed when the medium was supplemented by CaCl2
to a Ca + concentration of 1 m, while no effect was observed
at a Ca concentration in the medium of 0.45 mmol/liter. No
effect of PTH alone without PHA was observed.
Discussion
The present investigation has clearly shown that the prolifer-
ative response to PHA stimulation of T cells from uremic rats is
significantly enhanced compared to that of normal rats. Para-
thyroidectomy clearly inhibited the enhanced effect of the
uremic state on the T cell proliferation, and similarly a normal-
ization of the T cell response to PHA stimulation was demon-
strated after reversal of uremia and of the secondary hyper-
parathyroidism by a successful isogenic kidney transplantation.
Our results are different from the results from clinical studies.
The response of the uremic T cell to mitogen stimulation and
the single steps during activation of the T cells (antigen present-
ing cells, release of interleukin- 1, activation of immunocompe-
tent T-lymphocytes, expression of interleukin-2 receptors, pro-
duction of IL-2, differentiation to effector cells) have been the
subject of numerous clinical investigations. The results are
reversed plasma creatinine and plasma urea to normal levels,
just as PTH levels were normalized (Table 2).
The T cell response to PHA stimulation in vitro were signif-
icantly higher (P < 0.05) in cultures obtained from CRF rats
than in those obtained from normal rats of the same age (Fig. 1).
This enhanced lymphoproliferative response occurred at the
three different concentrations of PHA used. Unilateral nephrec-
tomy had no influence on the PHA stimulated T cell response
(Fig. 1).
Parathyroidectomy resulted in a significant reduction (P <
0.05) of the T cell response to PHA in both uremic and normal
rats. Sham parathyroidectomy did not significantly stimulate
the lymphoproliferative response. After PTX the T cells of
normal (Fig. 2) as well as of uremic rats (Fig. 3) could still
significantly (P < 0.05) be stimulated by PHA, but now no
significant difference was seen between the T cell responses to
PHA of CRF and normal rats.
When CRF was reversed after a successful isogenic kidney
transplantation and PTH reversed to levels within the normal
range, the T cell proliferative response to PHA was normalized
(Fig. 4).
The effects of increasing concentrations of rat PTH 1-84 on
PHA-induced T cell proliferation are shown in Figure 5. PTH
enhanced the PHA-stimulated 3H-thymidine uptake by PBMC
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patients on peritoneal dialysis [9, 15, 16]. A significantly re-
duced IL-2 production in supernatants of 48 hour cultures of
PHA stimulated T cells from hemodialyzed patients has been
reported in many studies [6, 7, 12], while T cells from patients
on peritoneal dialysis had a normal IL-2 production.
The results of the present investigation, showing an increased
proliferative response of T cells from CRF rats to PHA, are
different from, but not incompatible with the results from
clinical studies, taking into consideration the important differ-
ences between clinical studies and studies on a rat model such
as species differences, probably shorter duration of uremia in
the CRF rats, less severity of the secondary hyperparathyroid-
ism and no kidney replacement therapy. Based upon the
present results, it is suggested that the chronic secondary
hyperparathyroidism of uremia is responsible for the enhanced
proliferative response of T cells obtained from CRF rats. This is
supported by results showing that the difference between the
responses of T cells from normal rats and CRF rats disappeared
when the rats were parathyroidectomized. Uremia may en-
hance the sensitivity of lymphocytes to PTH, and the comito-
gene effect of PTH was in fact enhanced in uremic T cells. It has
been shown that IL-2 production by T cells is stimulated by a
rise in intracellular calcium [17]. It is possible that PTH
fascilitates calcium influx into the cells, and in this way stimu-
lates IL-2 production which again stimulates T cell prolifera-
tion. That PTH facilitates the influx of calcium into rat T cells
seems possible by the observation showing that the effect of
PTH was dependent upon a sufficient concentration of calcium
in the medium. Thus, PTH had no mitotic effect on T cells
maintained in a RPMI medium without calcium supplement (ion
calcium 0.45 mmollliter). In other cell types, Fraser and Arieff
[18] investigated the effect of PTH on calcium transport in the
rat brain synaptosomes. They found that the calcium uptake, in
response to PTH, in synaptosomes from uremic rats was
significantly greater than that from normal rats. A comparable












Fig. 3. T cell proliferative response to PHA stimulation in cultures







5 tg/mI 10 gIml 40 jig/mI 0 1 x 107M 2 x 107M 4 x 10M
PHA concentration 1 -84 PTH concentration
50
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Fig. 5. Effects of increasing concentrations of rat PTH 1-84 on PHA-
induced proliferation of T cells from CRF rats (A, N = 8) and normal







Normal rats CRF Transplanted
FIg. 4. Proliferative response to PHA 40 g/ml in Lewis rats PBMC
cultures before induction of uremia (normal rats, N = 7), during uremia(CRF, N = 7) and after reversal of uremia by isogenic kidney trans-
plantation (transplanted, N = 7). Data are mean 5EM. * P C 0.05
compared to results from nonnal and transplanted rats.
contradictory, often affected by different types of dialysis
treatment, as there may be some effect on the T cell function by
the dialysis itself [2, 6]. A reduced lymphocyte response to
stimulation with PHA has been reported in various studies [7, 8,
12, 13], although unchanged responses have also been reported
[2, 6]. Some studies suggest that the impaired functional re-
sponses seen in end-stage kidney disease patients on prolonged
hemodialysis treatment with cuprophane membranes are not
seen in similar patients hemodialyzed with polysulphone mem-
branes [61. Other studies have found that only a subpopulation
of hemodialyzed patients has an impaired T cell response [14].
Most studies find a normal proliferative response of T cells from
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increased proliferative response may reflect a serious patholog-
ical condition of the calcium transport through the plasma
membrane of the uremic T cells.
That IL-2 is a mediator of the comitogenic action of PTH has
been demonstrated by Alexiewicz et al [7]. They found that the
IL-2 production was enhanced during stimulation of normal
human T cells by both PTH and PHA as compared to stimula-
tion by PHA alone, while T cells from uremic patients failed to
increase the IL-2 production and proliferation in response to
both PHA and PHA + PTH, in contrast to the results of the
present investigation. However, that study was performed on
PBMC from patients on hemodialysis who presumably may
have a defect in IL-2 production at the transcriptional level due
to the hemodialysis treatment, and according to recent investi-
gations, it seems that patients on hemodialysis have a complete
loss of inducibiity of the IL-2 gene concomitant with a de-
creased inductibility of IFN-y mRNA [19]. By contrast, in
patients on peritoneal dialysis the expression of IL-2 mRNA
was as vigorous as in normal subjects, while IFN-y mRNA was
even more strongly inductible. It might therefore be that it was
the effect of treatment of terminal uremia and not only the effect
of uremia per se which was examined in the study of Alexiewicz
et al [7]. The results of the present study showing an enhanced
response to PTH by uremic rat T cells may indicate the validity
of such a discrimination between the uremic state and the
uremic state during treatment.
In both studies of Alexiewicz et al [7] and of Klinger et al [5]
PTH 1-84 augmented PHA-induced proliferative response of
normal human T cells. The differences between their results and
ours, which showed no significant effect of PTH on normal rat
T cells, may consist of differences in species (humans vs. rats)
but differences in conditions of cultures may provide a partial
explanation, too. They used 2 x i0 cells per well and a five day
culture in RPM! medium supplemented with fetal calf serum
without calcium addition, compared to our 5 x iø cells per
well, three day cultured, RPM! medium supplemented with a
rat serum and calcium. In addition, they used bovine PTH,
which might have a different potency from that of human or rat
PTH.
Concerning the possible effect of the extracellular calcium
concentration, it appears to play a central role in the control of
the mitotic activity in primary lymphoid tissue [20—23]. In fact
the mitotic activities of thymus and bone marrow cell popula-
tions in vivo and in vitro are proportional to the ionized calcium
concentrations in the blood and medium, respectively [24].
Such dependence is not considered to be present in the second-
ary immune system, which also indirectly appears from the
results of the present study. It was evident that secondary
hyperparathyroid uremic rats were not hypercalcemic and yet
they showed an increased lymphoprolipherative response. Aug-
mentation of the concentration of ionized calcium concentra-
tion in culture medium from 0.45 to 1.0 mmollliter was likewise
not by itself an increasing factor on the proliferative response of
T cells to PHA. However, it should be stressed that an
increased proliferative response of T cells in uremia have
nothing to do with an increased biological response of the T
cells per se.
Based upon the results of the present investigation—showing
(1.) that the proliferative response of T cells of uremic rats to
PHA stimulation was significantly enhanced compared to that
of normal rats; (2.) that parathyroidectomy clearly inhibited the
enhanced effect of uremia on the T cell proliferation; (3.) that a
normalization of the T cell response to PHA could be induced
after reversal of uremia and of the secondary hyperparathyroid-
ism by a successful isogenic kidney transplantation; and (4.)
that the effect of PTH on the PHA stimulated T cells took place
in a dose dependent manner—it is suggested that the response
of T cells in uremic rats are influenced by the high blood levels
of PTH often seen in chronic uremia.
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